Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

InMode Ltd. (INMD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
26.64+0.64 (+2.46%)
At close: 04:00PM EDT
26.90 +0.26 (+0.98%)
After hours: 07:59PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close23.77
Open24.11
Bid26.01 x 3200
Ask27.12 x 3000
Day's Range22.24 - 24.33
52 Week Range20.60 - 99.27
Volume2,605,702
Avg. Volume2,181,898
Market Cap2.035B
Beta (5Y Monthly)1.92
PE Ratio (TTM)15.35
EPS (TTM)1.74
Earnings DateFeb 08, 2022 - Feb 14, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est55.00
  • PR Newswire

    InMode to Participate at the UBS Healthcare One-on-One Virtual Day

    InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Moshe Mizrahy, Chief Executive Officer and Yair Malca, Chief Financial Officer, will participate at the UBS Healthcare One-on-One Virtual Day on June 1st, 2022. To schedule a meeting, please contact your UBS representative or Miri Segal at msegal@ms-ir.com.

  • Motley Fool

    1 Company Disrupting Plastic Surgery, Not Patients

    InMode's sales and profits have boomed, but you wouldn't know it from the company's share price.

  • Motley Fool

    This Is Why InMode Stock Fell 32% in April

    Shares of medical device company InMode (NASDAQ: INMD) fell 32% in April, according to data provided by S&P Global Market Intelligence. On April 11, the company gave encouraging preliminary financial results for the first quarter of 2022. Oddly enough, prominent analysts applauded the Q1 results from InMode but lowered their expectations for the stock nevertheless.

Advertisement
Advertisement